NGL Fine-Chem Limited Stock

Equities

NGLFINE

INE887E01022

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:50 2024-04-26 EDT 5-day change 1st Jan Change
2,639 INR -2.67% Intraday chart for NGL Fine-Chem Limited +3.73% +18.28%

Financials

Sales 2022 3.18B 38.08M 52.06M Sales 2023 2.78B 33.35M 45.6M Capitalization 7.39B 88.69M 121M
Net income 2022 499M 5.99M 8.18M Net income 2023 205M 2.46M 3.36M EV / Sales 2022 3.81 x
Net Debt 2022 4.52M 54.26K 74.18K Net cash position 2023 200M 2.4M 3.28M EV / Sales 2023 2.59 x
P/E ratio 2022
24.2 x
P/E ratio 2023
36.1 x
Employees 396
Yield 2022
0.09%
Yield 2023
0.15%
Free-Float 25.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.67%
1 week+3.73%
Current month+26.28%
1 month+24.84%
3 months+37.31%
6 months+47.67%
Current year+18.28%
More quotes
1 week
2 443.60
Extreme 2443.6
2 822.50
1 month
2 068.60
Extreme 2068.6
2 822.50
Current year
1 790.00
Extreme 1790
2 822.50
1 year
1 411.00
Extreme 1411
2 822.50
3 years
1 161.35
Extreme 1161.35
3 789.45
5 years
220.00
Extreme 220
3 789.45
10 years
19.70
Extreme 19.7
3 789.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 93-01-03
Director of Finance/CFO 48 05-05-31
Compliance Officer - 19-02-08
Members of the board TitleAgeSince
Chief Executive Officer 59 93-01-03
Director of Finance/CFO 48 05-05-31
Director/Board Member - 15-08-04
More insiders
Date Price Change Volume
24-04-26 2,639 -2.67% 1,134
24-04-25 2,712 +3.47% 2,550
24-04-24 2,621 +5.75% 2,570
24-04-23 2,478 -4.10% 1,214
24-04-22 2,584 +1.56% 2,857

Delayed Quote Bombay S.E., April 26, 2024 at 06:00 am

More quotes
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
More about the company
  1. Stock Market
  2. Equities
  3. NGLFINE Stock